Cervical cancer is the fourth most common type of gynecological cancer worldwide (Pimple et al., 2016). Most cervical cancer is caused by human papillomavirus (HPV) infection (Hashiguchi et al., 2019). There were 528,000 new cases every year, with 266,000 deaths in 2012 worldwide. In developing countries, cervical cancer also has high mortality rates among women (Pimple et al., 2016). There were 14,480 new cases in the United States in 2021 (American Cancer Society, 2021). ( American Cancer Society, 2021). The 5-year survival rate of cervical cancer for stage IB-IVA was 62.6% (Yoon et al., 2015).Recently, there has been increased research on cervical cancer stem cell (CCSC) markers. The role of these markers in cancer development has been extensively highlighted. Cancer stem cells (CSCs) are